| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 MYH6 ABCC4 MYH8 ABCA1 MYO9A UBA1 MDN1 ATP8A1 NAE1 KIF28P TAP1 RAD51B YTHDC2 CHD8 HELQ DNAH7 MSH6 ATP6V1H ATP2B1 ATP6V0A2 DNAH11 | 1.86e-09 | 614 | 196 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MAP2 SPTAN1 OBSCN PHKG1 EEF2K CEP97 CAMSAP3 CDK5RAP2 ATP2B1 | 8.93e-09 | 230 | 196 | 15 | GO:0005516 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 6.48e-08 | 12 | 196 | 5 | GO:0017154 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.69e-08 | 38 | 196 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.57e-07 | 118 | 196 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 MYH4 ABCC4 MYH8 ABCA1 MDN1 ATP8A1 KIF28P TAP1 RAD51B YTHDC2 CHD8 HELQ DNAH7 ATP6V1H ATP2B1 DNAH11 | 1.78e-06 | 441 | 196 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MAP2 MYO9A MARK3 SPTAN1 OBSCN ADGRV1 TUBGCP5 POF1B CEP350 BRCA1 ANLN KIF28P MLPH LIMA1 KRT10 CAMSAP3 LMO7 CDK5RAP2 DAAM2 TRAK2 MYBPC2 | 1.03e-05 | 1099 | 196 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYO9A SPTAN1 POF1B LIMA1 CAMSAP3 | 1.58e-05 | 227 | 196 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 CDHR2 SPTAN1 ADGRV1 KCNIP2 TENM2 TBC1D9 EPS15L1 DHH PCDH15 EEF2K FLG NID2 PCDHGA2 ANXA4 PCDHB3 PCDHA1 DNAH7 IHH PCDHGC3 PCDH9 | 1.59e-05 | 749 | 196 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MAP2 MYO9A SPTAN1 POF1B ANLN MLPH LIMA1 CAMSAP3 DAAM2 MYBPC2 | 2.16e-05 | 479 | 196 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MARK3 OBSCN ACVR1B PHKG1 PIK3CA PIM1 BTK EEF2K KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 DGKK PRKDC PIP4K2C ENG PSKH2 | 7.50e-05 | 709 | 196 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | MARK3 OBSCN ACVR1B PHKG1 PIK3CA PIM1 BTK EEF2K KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 PRKDC ENG PSKH2 | 9.32e-05 | 600 | 196 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | structural constituent of nuclear lamina | 9.59e-05 | 2 | 196 | 2 | GO:0160123 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.01e-04 | 109 | 196 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MARK3 OBSCN ACVR1B PHKG1 PIK3CA PIM1 EEF2K CDC42BPA LIMK2 IKBKE TBK1 PRKDC ENG PSKH2 | 1.38e-04 | 446 | 196 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | kinase activity | MARK3 OBSCN ACVR1B PHKG1 PIK3CA PIM1 BTK EEF2K KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 DGKK PRKDC PIP4K2C ENG PSKH2 | 1.97e-04 | 764 | 196 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | cholesterol-protein transferase activity | 2.86e-04 | 3 | 196 | 2 | GO:0140853 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | SERPINA3 GRIPAP1 PSD MYO9A PARK7 TBC1D2 OBSCN ADGRV1 ARHGEF11 ALS2CL ITIH3 TBC1D9 PIK3CA PIM1 BTK IQSEC1 PLXNB1 LILRB4 DOCK3 TBC1D15 NGB ANXA4 ARHGAP4 ATP6V1H WDR6 SERPINB2 CABIN1 DNAJC3 | 3.12e-04 | 1418 | 196 | 28 | GO:0030234 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | GRIPAP1 PSD MYO9A TBC1D2 OBSCN ARHGEF11 ALS2CL TBC1D9 IQSEC1 PLXNB1 DOCK3 TBC1D15 NGB ARHGAP4 | 5.05e-04 | 507 | 196 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | GRIPAP1 PSD MYO9A TBC1D2 OBSCN ARHGEF11 ALS2CL TBC1D9 IQSEC1 PLXNB1 DOCK3 TBC1D15 NGB ARHGAP4 | 5.05e-04 | 507 | 196 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | ubiquitin activating enzyme activity | 5.68e-04 | 4 | 196 | 2 | GO:0004839 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MARK3 OBSCN ACVR1B PHKG1 PIK3CA PIM1 BTK EEF2K KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 DGKK TNKS PRKDC PIP4K2C ENG PSKH2 | 9.49e-04 | 938 | 196 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 1.40e-03 | 6 | 196 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 MYH4 ABCC4 MYH8 ABCA1 MDN1 ATP8A1 KIF28P TAP1 RAD51B YTHDC2 CHD8 HELQ DNAH7 ATP6V1H ATP2B1 DNAH11 | 1.70e-03 | 775 | 196 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | GTPase activator activity | MYO9A TBC1D2 ARHGEF11 ALS2CL TBC1D9 PLXNB1 DOCK3 TBC1D15 ARHGAP4 | 1.80e-03 | 279 | 196 | 9 | GO:0005096 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.92e-03 | 178 | 196 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1.95e-03 | 7 | 196 | 2 | GO:0034485 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.94e-07 | 15 | 194 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 5.42e-07 | 18 | 194 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 9.10e-06 | 52 | 194 | 6 | GO:0071526 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABCA1 PSD MAP2 PARK7 SPTAN1 TBC1D2 TENM2 SETDB1 BRCA1 PIK3CA ANLN NAE1 BTK IQSEC1 EEF2K KIT CEP97 SEMA4D TBC1D15 UBE3B CAMSAP3 CEP192 LIMK2 IKBKE CDK5RAP2 DAAM2 PIP4K2C | 1.94e-05 | 1189 | 194 | 27 | GO:0044087 |
| GeneOntologyBiologicalProcess | microtubule-based process | CATSPERE MAP2 DRC1 ODAD4 TUBGCP5 CEP350 CFAP54 BRCA1 KIF28P KATNIP CEP97 CDC42BPA CAMSAP3 APOB TACC2 CEP192 DNAH7 TMEM230 DYDC1 LIMK2 LMNA CDK5RAP2 TNKS TRAK2 DNAH11 | 2.11e-05 | 1058 | 194 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MAP2 CDHR2 MYO9A TBC1D2 TENM2 FIG4 PIK3CA ANLN EEF2K KIT CEP97 PLXNA1 PLXNA2 PLXNB1 PLXNA3 SEMA4D TBC1D15 ARHGAP4 LIMK2 PLXNA4 DAAM2 TRAK2 | 2.21e-05 | 863 | 194 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | muscle contraction | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 ARHGEF11 KCNIP2 PIK3CA SCN4B KIT TPCN2 ATP2B1 MYBPC2 | 2.73e-05 | 400 | 194 | 14 | GO:0006936 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH3 MYH6 EPPK1 MAP2 PARK7 SPTAN1 OBSCN TUBGCP5 POF1B KRT39 PIK3CA PCDH15 EEF2K LIMA1 KRT10 KRT33A CAMSAP3 TACC2 CEP192 LIMK2 CDK5RAP2 DAAM2 MYBPC2 | 3.57e-05 | 957 | 194 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MAP2 CDHR2 TBC1D2 TENM2 FIG4 PIK3CA ANLN EEF2K KIT CEP97 PLXNA1 PLXNA2 PLXNB1 PLXNA3 SEMA4D TBC1D15 ARHGAP4 LIMK2 PLXNA4 DAAM2 TRAK2 | 5.04e-05 | 846 | 194 | 21 | GO:0120035 |
| GeneOntologyBiologicalProcess | negative regulation of developmental pigmentation | 8.80e-05 | 2 | 194 | 2 | GO:0048086 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 8.80e-05 | 2 | 194 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | MAP2 PLXNA1 PLXNA2 PLXNB1 PLXNA3 SEMA4D ARHGAP4 PLXNA4 TRAK2 | 8.81e-05 | 192 | 194 | 9 | GO:0050770 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH3 MYH4 MYH6 MYH8 SPTAN1 OBSCN ARHGEF11 POF1B PIK3CA ANLN SCN4B PCDH15 IQSEC1 EEF2K KIT LIMA1 CDC42BPA LIMK2 DAAM2 MYBPC2 | 1.45e-04 | 912 | 194 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | microtubule-based transport | MAP2 ODAD4 CFAP54 KIF28P KATNIP CAMSAP3 TMEM230 DYDC1 TRAK2 DNAH11 | 1.48e-04 | 253 | 194 | 10 | GO:0099111 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 MYH6 ABCC4 TBC1D2 OBSCN DRC1 ODAD4 TUBGCP5 CEP350 CFAP54 MDN1 BRCA1 ANLN PCDH15 CEP97 TBC1D15 CEP192 DNAH7 LIMK2 CDK5RAP2 TNKS PRKDC PIP4K2C MYBPC2 | 1.81e-04 | 1138 | 194 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | MAP2 SPTAN1 BRCA1 PIK3CA CEP97 LIMA1 CAMSAP3 CEP192 LIMK2 LMNA CDK5RAP2 TNKS PCID2 | 1.85e-04 | 421 | 194 | 13 | GO:0010639 |
| GeneOntologyBiologicalProcess | cilium movement | CATSPERE DRC1 ODAD4 CFAP54 KATNIP CAMSAP3 APOB DNAH7 DYDC1 DNAH11 | 1.90e-04 | 261 | 194 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.02e-04 | 127 | 194 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | intracellular pH reduction | 2.14e-04 | 58 | 194 | 5 | GO:0051452 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MAP2 MDN1 STXBP2 BTK KIF28P KIT MLPH CDC42BPA TACC2 TMEM230 LIMK2 LMNA LMNB1 CDK5RAP2 TRAK2 | 2.14e-04 | 546 | 194 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | muscle system process | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 ARHGEF11 KCNIP2 PIK3CA SCN4B KIT TPCN2 LMNA ATP2B1 MYBPC2 | 2.18e-04 | 547 | 194 | 15 | GO:0003012 |
| GeneOntologyBiologicalProcess | Golgi lumen acidification | 2.19e-04 | 13 | 194 | 3 | GO:0061795 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 2.32e-04 | 59 | 194 | 5 | GO:0003351 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CATSPERE MAP2 DRC1 ODAD4 CFAP54 KIF28P KATNIP CAMSAP3 APOB DNAH7 TMEM230 DYDC1 TRAK2 DNAH11 | 2.49e-04 | 493 | 194 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | protein splicing | 2.62e-04 | 3 | 194 | 2 | GO:0030908 | |
| GeneOntologyBiologicalProcess | intein-mediated protein splicing | 2.62e-04 | 3 | 194 | 2 | GO:0016539 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 2.62e-04 | 3 | 194 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | nuclear migration | 2.82e-04 | 34 | 194 | 4 | GO:0007097 | |
| GeneOntologyBiologicalProcess | extracellular transport | 2.93e-04 | 62 | 194 | 5 | GO:0006858 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ABCA1 PSD MYO9A OBSCN ARHGEF11 IQSEC1 PLXNB1 DOCK3 SEMA4D CDC42BPA ARHGAP4 | 3.29e-04 | 333 | 194 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | self proteolysis | 3.43e-04 | 15 | 194 | 3 | GO:0097264 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | MYO9A TBC1D2 ALS2CL TBC1D9 PLXNA1 PLXNA2 PLXNB1 PLXNA3 SEMA4D TBC1D15 PLXNA4 | 3.46e-04 | 335 | 194 | 11 | GO:0043087 |
| GeneOntologyCellularComponent | myosin filament | 4.88e-11 | 25 | 196 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.02e-09 | 13 | 196 | 6 | GO:0002116 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.66e-09 | 16 | 196 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 7.62e-08 | 59 | 196 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II complex | 2.00e-07 | 28 | 196 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH1 MYH2 EPPK1 PARK7 SPTAN1 OBSCN TENM2 POF1B UBA1 PIK3CA SCN4B KAZN KIT CDC42BPA CAMSAP3 ZAP70 LMO7 PCDHGC3 PCDH9 | 3.22e-06 | 591 | 196 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | MYH1 MYH2 IL16 EPPK1 CDHR2 PARK7 SPTAN1 TBC1D2 OBSCN TENM2 POF1B UBA1 PIK3CA SCN4B KAZN KIT LIMA1 CDC42BPA CAMSAP3 ZAP70 LMO7 ENG PCDHGC3 PCDH9 ATP6V0A2 | 5.11e-06 | 976 | 196 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 EPPK1 MAP2 MYO9A SPTAN1 OBSCN STYXL2 TUBGCP5 POF1B KRT39 KIF28P KRT10 KRT33A CAMSAP3 DNAH7 ARHGAP4 LMNA LMNB1 CDK5RAP2 DNAH11 MYBPC2 | 4.40e-05 | 1179 | 196 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 EPPK1 MAP2 MYO9A SPTAN1 OBSCN STYXL2 TUBGCP5 POF1B KRT39 KIF28P KRT10 KRT33A CAMSAP3 DNAH7 ARHGAP4 LMNA LMNB1 CDK5RAP2 DNAH11 MYBPC2 | 4.92e-05 | 1187 | 196 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | sarcomere | 1.27e-04 | 249 | 196 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | gamma-tubulin ring complex | 1.27e-04 | 11 | 196 | 3 | GO:0000931 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.58e-04 | 94 | 196 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | replication fork protection complex | 2.61e-04 | 3 | 196 | 2 | GO:0031298 | |
| GeneOntologyCellularComponent | myofibril | 2.66e-04 | 273 | 196 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.29e-04 | 290 | 196 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | intercalated disc | 4.45e-04 | 68 | 196 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | axoneme | 7.72e-04 | 207 | 196 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.96e-04 | 208 | 196 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | MAP2 DRC1 ODAD4 CFAP54 INPP5E CAMSAP3 DNAH7 DYDC1 TRAK2 DNAH11 | 8.53e-04 | 317 | 196 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | cell division site | 9.37e-04 | 80 | 196 | 5 | GO:0032153 | |
| GeneOntologyCellularComponent | gamma-tubulin complex | 9.53e-04 | 21 | 196 | 3 | GO:0000930 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MAP2 MYO9A SPTAN1 POF1B ANLN MLPH LIMA1 CDC42BPA | 1.12e-03 | 576 | 196 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | lamin filament | 1.28e-03 | 6 | 196 | 2 | GO:0005638 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.28e-03 | 6 | 196 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | A band | 1.43e-03 | 52 | 196 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 1.78e-03 | 7 | 196 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | cytoplasmic region | MAP2 DRC1 ODAD4 CFAP54 INPP5E CAMSAP3 DNAH7 DYDC1 TRAK2 DNAH11 | 2.19e-03 | 360 | 196 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | desmosome | 2.24e-03 | 28 | 196 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | pericentriolar material | 2.24e-03 | 28 | 196 | 3 | GO:0000242 | |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYO9A OBSCN IQSEC1 CEP97 UBE3B | 1.90e-10 | 71 | 196 | 11 | PF00612 |
| Domain | IQ_motif_EF-hand-BS | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYO9A OBSCN IQSEC1 CEP97 UBE3B | 2.59e-09 | 90 | 196 | 11 | IPR000048 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYO9A OBSCN IQSEC1 CEP97 UBE3B | 3.70e-09 | 93 | 196 | 11 | PS50096 |
| Domain | Myosin_N | 5.72e-09 | 15 | 196 | 6 | PF02736 | |
| Domain | Myosin_N | 5.72e-09 | 15 | 196 | 6 | IPR004009 | |
| Domain | IQ | 1.27e-08 | 81 | 196 | 10 | SM00015 | |
| Domain | Plexin_cytopl | 1.47e-08 | 9 | 196 | 5 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.47e-08 | 9 | 196 | 5 | IPR013548 | |
| Domain | Plexin | 1.47e-08 | 9 | 196 | 5 | IPR031148 | |
| Domain | Myosin_tail_1 | 2.07e-08 | 18 | 196 | 6 | PF01576 | |
| Domain | Myosin_tail | 2.07e-08 | 18 | 196 | 6 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 3.00e-08 | 19 | 196 | 6 | IPR027401 | |
| Domain | - | 3.00e-08 | 19 | 196 | 6 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 1.21e-07 | 38 | 196 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.21e-07 | 38 | 196 | 7 | PS51456 | |
| Domain | Myosin_head | 1.21e-07 | 38 | 196 | 7 | PF00063 | |
| Domain | MYSc | 1.21e-07 | 38 | 196 | 7 | SM00242 | |
| Domain | Semap_dom | 7.32e-07 | 31 | 196 | 6 | IPR001627 | |
| Domain | SEMA | 7.32e-07 | 31 | 196 | 6 | PS51004 | |
| Domain | Sema | 7.32e-07 | 31 | 196 | 6 | SM00630 | |
| Domain | Sema | 7.32e-07 | 31 | 196 | 6 | PF01403 | |
| Domain | Plexin_repeat | 8.93e-07 | 32 | 196 | 6 | IPR002165 | |
| Domain | PSI | 8.93e-07 | 32 | 196 | 6 | PF01437 | |
| Domain | PSI | 6.27e-06 | 44 | 196 | 6 | IPR016201 | |
| Domain | IPT | 8.09e-06 | 27 | 196 | 5 | SM00429 | |
| Domain | PSI | 8.17e-06 | 46 | 196 | 6 | SM00423 | |
| Domain | TIG | 1.65e-05 | 31 | 196 | 5 | PF01833 | |
| Domain | IPT | 1.93e-05 | 32 | 196 | 5 | IPR002909 | |
| Domain | Rho_GTPase_activation_prot | 3.90e-05 | 88 | 196 | 7 | IPR008936 | |
| Domain | Quino_amine_DH_bsu | 7.42e-05 | 22 | 196 | 4 | IPR011044 | |
| Domain | Cadherin_CS | 1.52e-04 | 109 | 196 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 1.90e-04 | 113 | 196 | 7 | PS00232 | |
| Domain | Cadherin | 1.90e-04 | 113 | 196 | 7 | PF00028 | |
| Domain | Protein_kinase_ATP_BS | MARK3 OBSCN ACVR1B PHKG1 PIM1 BTK KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 PSKH2 | 1.92e-04 | 379 | 196 | 13 | IPR017441 |
| Domain | Kinase-like_dom | MARK3 OBSCN ACVR1B PHKG1 PIK3CA PIM1 BTK EEF2K KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 PRKDC PSKH2 | 2.00e-04 | 542 | 196 | 16 | IPR011009 |
| Domain | CADHERIN_2 | 2.01e-04 | 114 | 196 | 7 | PS50268 | |
| Domain | - | 2.01e-04 | 114 | 196 | 7 | 2.60.40.60 | |
| Domain | CA | 2.12e-04 | 115 | 196 | 7 | SM00112 | |
| Domain | Cadherin-like | 2.24e-04 | 116 | 196 | 7 | IPR015919 | |
| Domain | Cadherin | 2.49e-04 | 118 | 196 | 7 | IPR002126 | |
| Domain | Hedgehog_signalling_dom | 3.26e-04 | 3 | 196 | 2 | IPR000320 | |
| Domain | HintN | 3.26e-04 | 3 | 196 | 2 | SM00306 | |
| Domain | HintC | 3.26e-04 | 3 | 196 | 2 | SM00305 | |
| Domain | Hedgehog | 3.26e-04 | 3 | 196 | 2 | IPR001657 | |
| Domain | HH_signal | 3.26e-04 | 3 | 196 | 2 | PF01085 | |
| Domain | Hint | 3.26e-04 | 3 | 196 | 2 | PF01079 | |
| Domain | Hedgehog_sig/DD-Pept_Zn-bd_dom | 3.26e-04 | 3 | 196 | 2 | IPR009045 | |
| Domain | Hint_dom | 3.26e-04 | 3 | 196 | 2 | IPR001767 | |
| Domain | - | 3.26e-04 | 3 | 196 | 2 | 3.30.1380.10 | |
| Domain | Hint_dom_N | 3.26e-04 | 3 | 196 | 2 | IPR003587 | |
| Domain | Hint_dom_C | 3.26e-04 | 3 | 196 | 2 | IPR003586 | |
| Domain | Intermediate_filament_CS | 5.19e-04 | 63 | 196 | 5 | IPR018039 | |
| Domain | Cadherin_2 | 6.00e-04 | 65 | 196 | 5 | PF08266 | |
| Domain | Cadherin_N | 6.00e-04 | 65 | 196 | 5 | IPR013164 | |
| Domain | Hedgehog/Intein_dom | 6.48e-04 | 4 | 196 | 2 | IPR028992 | |
| Domain | - | 6.48e-04 | 4 | 196 | 2 | 2.170.16.10 | |
| Domain | PH | PSD TBC1D2 OBSCN ARHGEF11 ANLN BTK IQSEC1 CDC42BPA SH2B3 DGKK | 7.33e-04 | 278 | 196 | 10 | SM00233 |
| Domain | PH_DOMAIN | PSD TBC1D2 OBSCN ARHGEF11 ANLN BTK IQSEC1 CDC42BPA SH2B3 DGKK | 7.53e-04 | 279 | 196 | 10 | PS50003 |
| Domain | PH_domain | PSD TBC1D2 OBSCN ARHGEF11 ANLN BTK IQSEC1 CDC42BPA SH2B3 DGKK | 7.74e-04 | 280 | 196 | 10 | IPR001849 |
| Domain | Ig_E-set | 8.01e-04 | 104 | 196 | 6 | IPR014756 | |
| Domain | AAA | 8.25e-04 | 144 | 196 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 8.25e-04 | 144 | 196 | 7 | IPR003593 | |
| Domain | Filament | 8.99e-04 | 71 | 196 | 5 | SM01391 | |
| Domain | IF | 9.58e-04 | 72 | 196 | 5 | PS00226 | |
| Domain | Filament | 1.02e-03 | 73 | 196 | 5 | PF00038 | |
| Domain | - | 1.07e-03 | 5 | 196 | 2 | 2.60.40.1260 | |
| Domain | YD | 1.07e-03 | 5 | 196 | 2 | IPR006530 | |
| Domain | Lamin_tail_dom | 1.07e-03 | 5 | 196 | 2 | IPR001322 | |
| Domain | LTD | 1.07e-03 | 5 | 196 | 2 | PF00932 | |
| Domain | PWWP | 1.14e-03 | 20 | 196 | 3 | SM00293 | |
| Domain | PROTEIN_KINASE_ATP | MARK3 OBSCN ACVR1B PHKG1 PIM1 BTK KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 PSKH2 | 1.16e-03 | 459 | 196 | 13 | PS00107 |
| Domain | IF | 1.22e-03 | 76 | 196 | 5 | IPR001664 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.36e-03 | 46 | 196 | 4 | IPR011042 | |
| Domain | PWWP | 1.73e-03 | 23 | 196 | 3 | PF00855 | |
| Domain | PWWP_dom | 1.73e-03 | 23 | 196 | 3 | IPR000313 | |
| Domain | PWWP | 1.96e-03 | 24 | 196 | 3 | PS50812 | |
| Domain | Prot_kinase_dom | MARK3 OBSCN ACVR1B PHKG1 PIM1 BTK KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 PSKH2 | 2.03e-03 | 489 | 196 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MARK3 OBSCN ACVR1B PHKG1 PIM1 BTK KIT CDC42BPA ZAP70 LIMK2 IKBKE TBK1 PSKH2 | 2.18e-03 | 493 | 196 | 13 | PS50011 |
| Domain | PH | 2.95e-03 | 229 | 196 | 8 | PF00169 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.46e-07 | 64 | 149 | 8 | M7923 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.00e-06 | 51 | 149 | 7 | MM14967 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.45e-06 | 9 | 149 | 4 | MM15030 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.11e-05 | 14 | 149 | 4 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.11e-05 | 14 | 149 | 4 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.49e-05 | 15 | 149 | 4 | MM15031 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.98e-05 | 16 | 149 | 4 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.98e-05 | 16 | 149 | 4 | M8245 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9A SPTAN1 OBSCN ARHGEF11 PIK3CA ANLN CEP97 PLXNA1 PLXNB1 DOCK3 CDC42BPA TRA2B ZAP70 ARHGAP4 LMNB1 WDR6 | 2.22e-05 | 450 | 149 | 16 | M27078 |
| Pathway | REACTOME_LIGAND_RECEPTOR_INTERACTIONS | 3.93e-05 | 7 | 149 | 3 | MM15224 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 4.11e-05 | 19 | 149 | 4 | M10959 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 5.09e-05 | 20 | 149 | 4 | M18415 | |
| Pathway | REACTOME_LIGAND_RECEPTOR_INTERACTIONS | 6.23e-05 | 8 | 149 | 3 | M27496 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9A SPTAN1 OBSCN ARHGEF11 PIK3CA ANLN CEP97 PLXNA1 PLXNB1 CDC42BPA TRA2B ZAP70 ARHGAP4 LMNB1 WDR6 | 6.37e-05 | 439 | 149 | 15 | MM15595 |
| Pathway | PID_HEDGEHOG_2PATHWAY | 7.56e-05 | 22 | 149 | 4 | M211 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SPTAN1 ARHGEF11 KRT39 PIK3CA KAZN KIT MLPH PLXNA1 PLXNA2 PLXNB1 PLXNA3 SEMA4D KRT10 COL6A6 KRT33A PLXNA4 | 8.19e-05 | 502 | 149 | 16 | MM14537 |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 9.47e-05 | 70 | 149 | 6 | M12294 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.08e-04 | 24 | 149 | 4 | M2243 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.79e-04 | 11 | 149 | 3 | MM15046 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 2.01e-04 | 28 | 149 | 4 | MM1396 | |
| Pathway | BIOCARTA_TNFR1_PATHWAY | 2.01e-04 | 28 | 149 | 4 | MM1516 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYO9A SPTAN1 OBSCN ARHGEF11 PIK3CA ANLN BTK CEP97 PLXNA1 PLXNB1 DOCK3 CDC42BPA TRA2B ZAP70 ARHGAP4 LIMK2 LMNB1 WDR6 TRAK2 | 2.10e-04 | 720 | 149 | 19 | M41838 |
| Pathway | BIOCARTA_TNFR1_PATHWAY | 2.32e-04 | 29 | 149 | 4 | M3618 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 2.65e-04 | 30 | 149 | 4 | M9503 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 3.87e-04 | 14 | 149 | 3 | M47414 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SPTAN1 ARHGEF11 PIK3CA PLXNA1 PLXNA2 PLXNB1 PLXNA3 SEMA4D COL6A6 PLXNA4 | 4.56e-04 | 261 | 149 | 10 | MM15676 |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 4.80e-04 | 15 | 149 | 3 | MM15037 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 4.86e-04 | 35 | 149 | 4 | MM15005 | |
| Pathway | KEGG_TIGHT_JUNCTION | 5.01e-04 | 132 | 149 | 7 | M11355 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYO9A SPTAN1 OBSCN ARHGEF11 PIK3CA ANLN BTK CEP97 PLXNA1 PLXNB1 CDC42BPA TRA2B ZAP70 ARHGAP4 LMNB1 WDR6 TRAK2 | 5.02e-04 | 649 | 149 | 17 | MM15690 |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 5.43e-04 | 36 | 149 | 4 | M18647 | |
| Pathway | WP_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION | 5.43e-04 | 36 | 149 | 4 | MM15967 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 6.04e-04 | 37 | 149 | 4 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 6.04e-04 | 37 | 149 | 4 | MM15610 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 6.69e-04 | 38 | 149 | 4 | M39549 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 1.10e-03 | 110 | 149 | 6 | M48043 | |
| Pubmed | EFCAB5 MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 SPTAN1 MDN1 STXBP2 BRCA1 MLPH PLXNA2 ZNF541 RAD51B PLXNA3 FLG LIMA1 KRT10 KRT33A PCDHGA2 CAMSAP3 APOB TMEM230 LMNA LMNB1 LMO7 DGKK PLXNA4 PRKDC ATP2B1 PCDHGC3 DNAJC3 PCID2 RBFA MYBPC2 | 7.31e-14 | 1442 | 198 | 36 | 35575683 | |
| Pubmed | 2.20e-13 | 7 | 198 | 6 | 16819597 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 5.69e-12 | 5 | 198 | 5 | 3829126 | |
| Pubmed | 5.69e-12 | 5 | 198 | 5 | 6196357 | ||
| Pubmed | 3.40e-11 | 6 | 198 | 5 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.40e-11 | 6 | 198 | 5 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.40e-11 | 6 | 198 | 5 | 10588881 | |
| Pubmed | 5.24e-11 | 13 | 198 | 6 | 10520995 | ||
| Pubmed | 1.18e-10 | 7 | 198 | 5 | 35210422 | ||
| Pubmed | 3.14e-10 | 8 | 198 | 5 | 3864153 | ||
| Pubmed | 3.14e-10 | 8 | 198 | 5 | 15661641 | ||
| Pubmed | 7.03e-10 | 9 | 198 | 5 | 19909241 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SPTAN1 TBC1D2 KDM3B TBC1D9 WWC2 EPS15L1 UBA1 MDN1 ANLN IQSEC1 UTP20 TIMELESS LIMA1 SFSWAP CAMSAP3 USP24 YTHDC2 MSH6 LMNA LMO7 PRKDC ZC3HAV1 | 7.40e-10 | 774 | 198 | 22 | 15302935 |
| Pubmed | 1.02e-09 | 4 | 198 | 4 | 20357587 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 1.02e-09 | 4 | 198 | 4 | 25518740 | |
| Pubmed | 1.02e-09 | 4 | 198 | 4 | 1985022 | ||
| Pubmed | 1.02e-09 | 4 | 198 | 4 | 11306810 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 1.02e-09 | 4 | 198 | 4 | 8570614 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 EPPK1 PARK7 SPTAN1 POF1B UBA1 MDN1 TBC1D15 LIMA1 KRT33A LMNA LMNB1 LMO7 PRKDC ATP2B1 | 1.11e-09 | 647 | 198 | 20 | 26618866 |
| Pubmed | 2.18e-09 | 22 | 198 | 6 | 24301466 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 4.36e-09 | 12 | 198 | 5 | 21270798 | |
| Pubmed | GRIPAP1 KDM3B ACVR1B CEP350 EPS15L1 BRCA1 EEF2K KRT10 CDC42BPA SFSWAP NBEA APOB CEP192 FAM171B DNAH7 LMNB1 CDK5RAP2 PRKDC PCDH9 ATP6V0A2 ZC3HAV1 | 4.47e-09 | 777 | 198 | 21 | 35844135 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 5.07e-09 | 5 | 198 | 4 | 12919077 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP2 MYO9A MARK3 SPTAN1 KDM3B CEP350 WWC2 MDN1 ANLN IQSEC1 LIMA1 CDC42BPA TRA2B INPP5E CAMSAP3 CEP192 DNAH7 LIMK2 LMO7 IKBKE ATP2B1 ZC3HAV1 | 5.18e-09 | 861 | 198 | 22 | 36931259 |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 7.05e-09 | 13 | 198 | 5 | 8404542 | |
| Pubmed | 1.07e-08 | 28 | 198 | 6 | 18617019 | ||
| Pubmed | 1.09e-08 | 14 | 198 | 5 | 27184118 | ||
| Pubmed | 2.36e-08 | 16 | 198 | 5 | 22090424 | ||
| Pubmed | 2.36e-08 | 16 | 198 | 5 | 17356169 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 3.33e-08 | 17 | 198 | 5 | 17626059 | |
| Pubmed | 3.33e-08 | 17 | 198 | 5 | 11683995 | ||
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 3.52e-08 | 7 | 198 | 4 | 19655386 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 3.52e-08 | 7 | 198 | 4 | 19063725 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 3.52e-08 | 7 | 198 | 4 | 29758057 | |
| Pubmed | PARK7 SPTAN1 BTBD9 ARHGEF11 TENM2 EPS15L1 UBA1 MDN1 IQSEC1 LIMA1 TRA2B CAMSAP3 NSD1 CHD8 NBEA PREPL LMNB1 TBK1 CDK5RAP2 TNKS PIP4K2C CABIN1 | 3.79e-08 | 963 | 198 | 22 | 28671696 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH3 MYH4 NEXMIF TBC1D2 OBSCN ACVR1B MDN1 EXOC3L4 UTP20 KAZN CAMSAP3 NBEA MSH6 LMNA LMNB1 TBK1 PLXNA4 PRKDC | 5.20e-08 | 736 | 198 | 19 | 29676528 |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 7.01e-08 | 8 | 198 | 4 | 14667415 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 7.01e-08 | 8 | 198 | 4 | 22368082 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 PCNX3 OBSCN KDM3B ARHGEF11 TBC1D9 EPS15L1 MDN1 PLXNA1 DOCK3 PLXNA3 CDC42BPA SH2B3 INPP5E UBE3B NSD1 CHD8 CEP192 BTBD7 ZFYVE26 PRKDC CABIN1 SOWAHB | 9.74e-08 | 1105 | 198 | 23 | 35748872 |
| Pubmed | SPTAN1 KDM3B EPS15L1 UBA1 ANLN TBC1D15 LIMA1 USP24 NSD1 CHD8 MSH6 LMNB1 LMO7 WDR6 PRKDC ZC3HAV1 | 1.22e-07 | 549 | 198 | 16 | 38280479 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 18625214 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 1.82e-07 | 3 | 198 | 3 | 11241833 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 27397516 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.82e-07 | 3 | 198 | 3 | 26059207 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 8806646 | ||
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 2.08e-07 | 10 | 198 | 4 | 18804103 | |
| Pubmed | 2.08e-07 | 10 | 198 | 4 | 19506036 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 2.08e-07 | 10 | 198 | 4 | 8950513 | |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 2.21e-07 | 24 | 198 | 5 | 28893946 | |
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 2.21e-07 | 24 | 198 | 5 | 15869472 | |
| Pubmed | EPS15L1 UBA1 ANLN EEF2K TIMELESS TBC1D15 TRA2B CAMSAP3 USP24 CHD8 TACC2 MSH6 LMNA LMO7 ZC3HAV1 | 2.30e-07 | 503 | 198 | 15 | 16964243 | |
| Pubmed | MARK3 KDM3B ACVR1B GALNT13 UBA1 ATP8A1 CES4A PLXNA1 PLXNA3 SEMA4D CDC42BPA USP24 NSD1 DGKK HARS1 ATP2B1 ATP6V0A2 DNAH11 | 2.33e-07 | 730 | 198 | 18 | 34857952 | |
| Pubmed | 2.79e-07 | 47 | 198 | 6 | 35462405 | ||
| Pubmed | 3.26e-07 | 11 | 198 | 4 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 3.26e-07 | 11 | 198 | 4 | 16024798 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 3.26e-07 | 11 | 198 | 4 | 38303699 | |
| Pubmed | 4.87e-07 | 12 | 198 | 4 | 23991118 | ||
| Pubmed | 4.87e-07 | 12 | 198 | 4 | 25839327 | ||
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 4.87e-07 | 12 | 198 | 4 | 24179230 | |
| Pubmed | 4.87e-07 | 12 | 198 | 4 | 31690636 | ||
| Pubmed | 4.87e-07 | 12 | 198 | 4 | 28407732 | ||
| Pubmed | 5.17e-07 | 52 | 198 | 6 | 26633812 | ||
| Pubmed | MYH6 IL16 MAP2 MYO9A MARK3 PARK7 SPTAN1 ARHGEF11 EPS15L1 UBA1 ATP8A1 IQSEC1 LIMA1 KRT10 CAMSAP3 YTHDC2 NBEA ATP6V1H LMNA LMO7 PLXNA4 LRRCC1 PIP4K2C ATP2B1 DNAH11 | 6.92e-07 | 1431 | 198 | 25 | 37142655 | |
| Pubmed | 7.00e-07 | 13 | 198 | 4 | 11604131 | ||
| Pubmed | Functional assembly of accessory optic system circuitry critical for compensatory eye movements. | 7.00e-07 | 13 | 198 | 4 | 25959730 | |
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 7.00e-07 | 13 | 198 | 4 | 22723296 | |
| Pubmed | 7.00e-07 | 13 | 198 | 4 | 8948582 | ||
| Pubmed | Semaphorin-plexin signalling genes associated with human breast tumourigenesis. | 7.24e-07 | 4 | 198 | 3 | 21925246 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 7.24e-07 | 4 | 198 | 3 | 18417546 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 10388558 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 11023856 | ||
| Pubmed | Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. | 7.24e-07 | 4 | 198 | 3 | 21346760 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 7.24e-07 | 4 | 198 | 3 | 11029314 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 20877282 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 10725340 | ||
| Pubmed | 9.76e-07 | 14 | 198 | 4 | 24938781 | ||
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 9.76e-07 | 14 | 198 | 4 | 20159958 | |
| Pubmed | 9.98e-07 | 58 | 198 | 6 | 21884692 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.19e-06 | 33 | 198 | 5 | 32094117 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 1.32e-06 | 15 | 198 | 4 | 24852826 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.76e-06 | 16 | 198 | 4 | 19922871 | |
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 1.76e-06 | 16 | 198 | 4 | 18489001 | |
| Pubmed | 1.78e-06 | 100 | 198 | 7 | 21800051 | ||
| Pubmed | 1.80e-06 | 5 | 198 | 3 | 25313870 | ||
| Pubmed | 1.80e-06 | 5 | 198 | 3 | 6879174 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.80e-06 | 5 | 198 | 3 | 30737693 | |
| Pubmed | Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. | 1.80e-06 | 5 | 198 | 3 | 10050855 | |
| Pubmed | BRPF3 IL16 PSD TUBGCP5 SETDB1 BRCA1 IQSEC1 NID2 SFSWAP YTHDC2 CHD8 ZKSCAN2 ARHGAP4 MSH6 LIMK2 WDR6 NT5DC2 TBK1 SMARCD1 PIP4K2C PCID2 | 1.82e-06 | 1116 | 198 | 21 | 31753913 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.91e-06 | 101 | 198 | 7 | 24613305 | |
| Pubmed | 2.29e-06 | 17 | 198 | 4 | 16124007 | ||
| Pubmed | 2.80e-06 | 39 | 198 | 5 | 38690566 | ||
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 2.93e-06 | 18 | 198 | 4 | 25753484 | |
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 3.59e-06 | 6 | 198 | 3 | 17559643 | |
| Pubmed | 3.59e-06 | 6 | 198 | 3 | 20417199 | ||
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 3.59e-06 | 6 | 198 | 3 | 19480842 | |
| Pubmed | 3.60e-06 | 210 | 198 | 9 | 16565220 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 SPTAN1 SETDB1 UBA1 MDN1 ANLN CHD8 MSH6 LMNA LMO7 PRKDC | 3.61e-06 | 332 | 198 | 11 | 32786267 |
| Pubmed | MAP2 MARK3 PARK7 SPTAN1 DNAJB9 MDN1 NAE1 SLC39A6 EEF2K TBC1D15 CDC42BPA CEP192 PREPL NBAS LMNA LMNB1 PTCD1 WDR6 NT5DC2 CDK5RAP2 ATP2B1 DNAJC3 ATP6V0A2 ZC3HAV1 | 4.58e-06 | 1487 | 198 | 24 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 MAP2 MYO9A MARK3 OBSCN ADGRV1 BTBD9 KCNIP2 TTF1 EPS15L1 SLC9A7 KATNIP MLPH RAD51B SEMA4D TPCN2 CDC42BPA ANXA4 CAMSAP3 CEP192 TBK1 ATP2B1 DNAJC3 ZC3HAV1 | 4.68e-06 | 1489 | 198 | 24 | 28611215 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | EPPK1 MAP2 SPTAN1 OBSCN EXOC3L4 CEP97 NID2 LIMA1 KRT10 KRT33A UBE3B LMNA PRKDC MYBPC2 | 4.96e-06 | 564 | 198 | 14 | 21565611 |
| Interaction | SEMA5A interactions | 2.97e-07 | 7 | 196 | 4 | int:SEMA5A | |
| Interaction | TSPAN33 interactions | 3.19e-06 | 65 | 196 | 7 | int:TSPAN33 | |
| Interaction | AURKC interactions | 3.54e-06 | 43 | 196 | 6 | int:AURKC | |
| Interaction | WWTR1 interactions | IL16 SPTAN1 TTF1 EPS15L1 UBA1 ANLN TBC1D15 LIMA1 USP24 CHD8 MSH6 LMNB1 LMO7 WDR6 ENG ZC3HAV1 | 4.00e-06 | 422 | 196 | 16 | int:WWTR1 |
| Interaction | ABTB2 interactions | 6.47e-06 | 101 | 196 | 8 | int:ABTB2 | |
| Interaction | SEMA5B interactions | 1.09e-05 | 15 | 196 | 4 | int:SEMA5B | |
| Interaction | GJA1 interactions | MYH6 PCNX3 MARK3 SPTAN1 STXBP2 PIK3CA SLC39A6 CDC42BPA NBEA APOB FAM171B NBAS LMNA LMNB1 WDR6 ATP2B1 PCDH9 ZC3HAV1 | 1.67e-05 | 583 | 196 | 18 | int:GJA1 |
| Interaction | ASAH2 interactions | 1.77e-05 | 6 | 196 | 3 | int:ASAH2 | |
| Interaction | RSPH6A interactions | 1.83e-05 | 34 | 196 | 5 | int:RSPH6A | |
| Interaction | PRKACB interactions | 2.01e-05 | 193 | 196 | 10 | int:PRKACB | |
| Interaction | RHOB interactions | EPPK1 PCNX3 MYO9A MARK3 SPTAN1 ACVR1B ARHGEF11 TENM2 UBA1 MDN1 ANLN IQSEC1 SLC39A6 UTP20 PLXNA1 CDC42BPA NBEA FAM171B WDR6 PIP4K2C ATP2B1 ZC3HAV1 | 2.44e-05 | 840 | 196 | 22 | int:RHOB |
| Interaction | PRKAG2 interactions | 5.20e-05 | 68 | 196 | 6 | int:PRKAG2 | |
| Interaction | KRT18 interactions | EPPK1 CEP350 UBA1 BRCA1 ANLN CEP97 FLG KRT10 CDC42BPA CEP192 TBK1 SMARCD1 HARS1 DNAJC3 | 6.47e-05 | 419 | 196 | 14 | int:KRT18 |
| Interaction | SEMA6D interactions | 6.65e-05 | 23 | 196 | 4 | int:SEMA6D | |
| Interaction | EPB41L4A interactions | 6.93e-05 | 140 | 196 | 8 | int:EPB41L4A | |
| Interaction | CCDC8 interactions | EPPK1 CEP350 UBA1 MDN1 STXBP2 UTP20 TAP1 TBC1D15 LIMA1 TRA2B YTHDC2 APOB LMNA LMNB1 LMO7 TBK1 PRKDC ATP2B1 | 7.73e-05 | 656 | 196 | 18 | int:CCDC8 |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 MYH8 PARK7 SPTAN1 SETDB1 BRCA1 PIK3CA ANLN DESI1 TBC1D15 CDC42BPA CAMSAP3 USP24 CHD8 MSH6 LMNB1 LMO7 WDR6 TBK1 SKOR1 SMARCD1 CDK5RAP2 CABIN1 | 7.74e-05 | 1108 | 196 | 25 | int:HDAC1 |
| Interaction | STX4 interactions | GRIPAP1 MARK3 SPTAN1 STXBP2 SLC39A6 CDC42BPA FAM171B NBAS LMNA LMNB1 WDR6 TBK1 ATP2B1 ZC3HAV1 | 8.11e-05 | 428 | 196 | 14 | int:STX4 |
| Interaction | CFTR interactions | MYH1 SERPINA3 MYH2 MYH3 MYH4 MYH6 ABCC4 MYH8 EPPK1 PARK7 SPTAN1 PDZK1 MEIOB POF1B UBA1 MDN1 ANLN FLG TBC1D15 LIMA1 KRT10 KRT33A LMNA LMNB1 PTCD1 LMO7 SMARCD1 ZFYVE26 PRKDC ATP2B1 | 1.00e-04 | 1480 | 196 | 30 | int:CFTR |
| Interaction | HHIP interactions | 1.03e-04 | 10 | 196 | 3 | int:HHIP | |
| Interaction | LATS1 interactions | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 SPTAN1 CEP350 WWC2 MDN1 CEP192 LMNA CDK5RAP2 MYBPC2 | 1.09e-04 | 440 | 196 | 14 | int:LATS1 |
| Cytoband | 5q31 | 1.48e-04 | 115 | 198 | 5 | 5q31 | |
| Cytoband | 17p13.1 | 1.67e-04 | 118 | 198 | 5 | 17p13.1 | |
| GeneFamily | Myosin heavy chains | 6.41e-10 | 15 | 132 | 6 | 1098 | |
| GeneFamily | Plexins | 2.37e-09 | 9 | 132 | 5 | 683 | |
| GeneFamily | Lamins | 1.58e-04 | 3 | 132 | 2 | 612 | |
| GeneFamily | PWWP domain containing | 5.29e-04 | 22 | 132 | 3 | 1147 | |
| GeneFamily | Keratins, type I | 1.09e-03 | 28 | 132 | 3 | 608 | |
| GeneFamily | EF-hand domain containing | 1.14e-03 | 219 | 132 | 7 | 863 | |
| GeneFamily | Clustered protocadherins | 1.23e-03 | 64 | 132 | 4 | 20 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 2.29e-03 | 10 | 132 | 2 | 100 | |
| Coexpression | GSE17580_TREG_VS_TEFF_UP | 3.12e-06 | 200 | 198 | 10 | M3670 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | MYH1 MYH4 IL16 NEXMIF MEIOB KRT39 SERPINB2 SKOR1 DAAM2 PCDH9 MYBPC2 | 4.83e-06 | 259 | 198 | 11 | M9331 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.39e-05 | 20 | 198 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.71e-05 | 21 | 198 | 4 | MM1102 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | SPTAN1 ARHGEF11 TUBGCP5 ANLN CDC42BPA CEP192 ARHGAP4 LMNB1 CDK5RAP2 | 2.18e-05 | 199 | 198 | 9 | M5893 |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | MAP2 ADGRV1 ACVR1B DNAJB9 TENM2 MLPH PLXNA2 KRT10 NBEA PREPL | 2.20e-05 | 250 | 198 | 10 | M39170 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | MYH1 MYH4 IL16 NEXMIF MEIOB KRT39 SERPINB2 SKOR1 DAAM2 PCDH9 MYBPC2 | 2.52e-05 | 309 | 198 | 11 | MM1244 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | MYH4 CDHR2 MYO9A OBSCN MEIOB ADGRV1 TENM2 WWC2 KAZN MLPH DOCK3 FLG BPIFC PCDHGA2 ZAP70 PLXNA4 CNTNAP4 DNAJC3 TREML2 | 3.77e-05 | 873 | 198 | 19 | M16009 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 4.01e-05 | 166 | 198 | 8 | M6826 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | TTC23L DRC1 ODAD4 ARHGEF11 CFAP54 CES4A SPATS1 MLPH CEP97 USP24 NBEA DNAH7 DNAH11 | 5.06e-05 | 459 | 198 | 13 | M39136 |
| Coexpression | LEE_LIVER_CANCER_SURVIVAL_DN | 7.10e-05 | 180 | 198 | 8 | M7987 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MYH3 ABCC4 ABCA1 MAP2 BCAT1 TENM2 TBC1D9 CEP350 SETDB1 ATP8A1 SLC35D3 LANCL3 TRA2B PCDHB3 NSD1 FAM171B HHIP LMNB1 DGKK TSPAN8 CNTNAP4 ATP2B1 | 4.77e-06 | 818 | 191 | 22 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | MYH3 MAP2 TENM2 CEP350 SETDB1 ATP8A1 SLC35D3 LANCL3 PCDHB3 NSD1 FAM171B HHIP LMNB1 DGKK CNTNAP4 | 7.94e-06 | 427 | 191 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_500 | 4.62e-05 | 105 | 191 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ABCC4 BCAT1 ADGRV1 ATP8A1 PLXNA2 PLXNB1 TRA2B CAMSAP3 HHIP LMO7 | 2.36e-08 | 200 | 198 | 10 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 184 | 198 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 184 | 198 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 184 | 198 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-07 | 186 | 198 | 9 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-07 | 186 | 198 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-07 | 187 | 198 | 9 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-07 | 194 | 198 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.59e-07 | 197 | 198 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.59e-07 | 197 | 198 | 9 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.08e-07 | 163 | 198 | 8 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 7.08e-07 | 163 | 198 | 8 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 175 | 198 | 8 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-06 | 179 | 198 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.49e-06 | 180 | 198 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-06 | 183 | 198 | 8 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-06 | 188 | 198 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-06 | 133 | 198 | 7 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.33e-06 | 191 | 198 | 8 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 193 | 198 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 193 | 198 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-06 | 193 | 198 | 8 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 199 | 198 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-06 | 199 | 198 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 199 | 198 | 8 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.15e-06 | 199 | 198 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.15e-06 | 199 | 198 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 5.19e-06 | 151 | 198 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.29e-06 | 159 | 198 | 7 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-05 | 171 | 198 | 7 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 1.26e-05 | 173 | 198 | 7 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.31e-05 | 174 | 198 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-05 | 175 | 198 | 7 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 175 | 198 | 7 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.58e-05 | 179 | 198 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 180 | 198 | 7 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 181 | 198 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 182 | 198 | 7 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 182 | 198 | 7 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 183 | 198 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 183 | 198 | 7 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 184 | 198 | 7 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 184 | 198 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 185 | 198 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 185 | 198 | 7 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.95e-05 | 185 | 198 | 7 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 185 | 198 | 7 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 186 | 198 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 2.02e-05 | 186 | 198 | 7 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 187 | 198 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 188 | 198 | 7 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.24e-05 | 189 | 198 | 7 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.24e-05 | 189 | 198 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.24e-05 | 189 | 198 | 7 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 127 | 198 | 6 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 127 | 198 | 6 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 191 | 198 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.39e-05 | 191 | 198 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 191 | 198 | 7 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 191 | 198 | 7 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 191 | 198 | 7 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 191 | 198 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 191 | 198 | 7 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.47e-05 | 192 | 198 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-05 | 192 | 198 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 130 | 198 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.56e-05 | 193 | 198 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.56e-05 | 193 | 198 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 194 | 198 | 7 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 194 | 198 | 7 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 194 | 198 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 390C|World / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-05 | 195 | 198 | 7 | b955e83c2bf7a7e20ee50fab9dc9678f36d5bfd6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 195 | 198 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.73e-05 | 195 | 198 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 195 | 198 | 7 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-05 | 195 | 198 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.91e-05 | 197 | 198 | 7 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 197 | 198 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-05 | 197 | 198 | 7 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 197 | 198 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.91e-05 | 197 | 198 | 7 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 198 | 198 | 7 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 198 | 198 | 7 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 198 | 198 | 7 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 198 | 198 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.01e-05 | 198 | 198 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 198 | 198 | 7 | 27f0654fb0857e93f030e1a4b1c307b31576bbcd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.01e-05 | 198 | 198 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 199 | 198 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 198 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 200 | 198 | 7 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 200 | 198 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.21e-05 | 200 | 198 | 7 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.21e-05 | 200 | 198 | 7 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 200 | 198 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-05 | 200 | 198 | 7 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.53e-05 | 144 | 198 | 6 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 145 | 198 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.28e-05 | 148 | 198 | 6 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| Computational | Neighborhood of THRA | 4.28e-05 | 54 | 129 | 6 | MORF_THRA | |
| Computational | Neighborhood of FOSL1 | MYH2 IL16 PSD MAP2 ZNF202 ITIH3 BRCA1 FIG4 KAZN PLXNA3 CDC42BPA KRT33A INPP5E TACC2 ATP6V0A2 | 1.02e-04 | 406 | 129 | 15 | MORF_FOSL1 |
| Computational | Neighborhood of NOS2A | MYH2 IL16 PSD MAP2 ZNF202 ITIH3 BRCA1 FIG4 PLXNA3 KRT33A TACC2 ATP6V0A2 | 1.74e-04 | 288 | 129 | 12 | MORF_NOS2A |
| Computational | Neighborhood of BRCA1 | IL16 MAP2 ZNF202 ITIH3 BRCA1 FIG4 KAZN KRT33A INPP5E IKBKE ATP6V0A2 | 3.17e-04 | 263 | 129 | 11 | MORF_BRCA1 |
| Computational | Neighborhood of PAX7 | MYH2 ABCA1 PSD ZNF202 BRCA1 FIG4 KAZN PLXNA3 KRT33A TACC2 ATP6V0A2 | 3.49e-04 | 266 | 129 | 11 | MORF_PAX7 |
| Drug | purealin | 3.75e-08 | 58 | 198 | 8 | CID006419303 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MAP2 MYO9A SPTAN1 TBC1D9 PHKG1 EEF2K ANXA4 CABIN1 ATP2B1 | 1.73e-07 | 324 | 198 | 15 | CID000005566 |
| Drug | formycin triphosphate | 2.83e-07 | 51 | 198 | 7 | CID000122274 | |
| Drug | fast white | 1.62e-06 | 42 | 198 | 6 | CID000024008 | |
| Drug | blebbistatin | 8.09e-06 | 116 | 198 | 8 | CID003476986 | |
| Drug | B0683 | 8.62e-06 | 117 | 198 | 8 | CID006398969 | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; HL60; HT_HG-U133A | ABCA1 ACVR1B MLPH PLXNB1 CDC42BPA LMNA BTBD7 TSPAN8 SMARCD1 DAAM2 | 9.28e-06 | 197 | 198 | 10 | 2922_UP |
| Drug | oxovanadium | 1.04e-05 | 120 | 198 | 8 | CID000024411 | |
| Drug | AC1L1CB3 | 1.54e-05 | 18 | 198 | 4 | CID000001818 | |
| Drug | nocodazole | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MAP2 CEP350 EPS15L1 STXBP2 COG2 ARHGAP4 LIMK2 LMNA LMNB1 | 1.99e-05 | 477 | 198 | 15 | CID000004122 |
| Drug | S-(-)-Etomoxir | 2.74e-05 | 100 | 198 | 7 | CID000060765 | |
| Drug | clenbuterol | 3.52e-05 | 142 | 198 | 8 | CID000002783 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.49e-11 | 10 | 193 | 6 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.44e-11 | 48 | 193 | 9 | DOID:423 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 6.48e-11 | 12 | 193 | 6 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 6.48e-11 | 12 | 193 | 6 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.20e-10 | 13 | 193 | 6 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.45e-10 | 15 | 193 | 6 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH1 RTP1 CATSPERE SPTAN1 PDZK1 OBSCN ALS2CL BRCA1 PIK3CA PIM1 BTK SLC39A6 UTP20 TIMELESS KIT PLXNB1 ZNF541 RAD51B NID2 TACC2 HELQ MSH6 SERPINB2 SMARCD1 ZFYVE26 | 4.15e-08 | 1074 | 193 | 25 | C0006142 |
| Disease | Adenocarcinoma of large intestine | 2.35e-07 | 96 | 193 | 8 | C1319315 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 7.29e-06 | 71 | 193 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.46e-05 | 80 | 193 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 1.27e-04 | 3 | 193 | 2 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 1.27e-04 | 3 | 193 | 2 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 1.27e-04 | 3 | 193 | 2 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 1.27e-04 | 3 | 193 | 2 | DOID:0070247 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.49e-04 | 41 | 193 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.49e-04 | 41 | 193 | 4 | C0858252 | |
| Disease | primary biliary cirrhosis | 2.50e-04 | 133 | 193 | 6 | EFO_1001486 | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 2.53e-04 | 4 | 193 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | semaphorin-4D measurement | 2.53e-04 | 4 | 193 | 2 | EFO_0802050 | |
| Disease | Usher Syndrome | 2.53e-04 | 4 | 193 | 2 | C0271097 | |
| Disease | Primary Ciliary Dyskinesia | 2.54e-04 | 47 | 193 | 4 | C4551720 | |
| Disease | Hypospadias | 4.20e-04 | 5 | 193 | 2 | C0848558 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.33e-04 | 206 | 193 | 7 | C0152013 | |
| Disease | smoking behavior | TENM2 PCDH15 PLXNA2 CDC42BPA TRA2B PTCD1 PLXNA4 CNTNAP4 PCDH9 | 4.37e-04 | 341 | 193 | 9 | EFO_0004318 |
| Disease | airway responsiveness measurement | 5.04e-04 | 24 | 193 | 3 | EFO_0006897 | |
| Disease | Adenoid Cystic Carcinoma | 5.18e-04 | 100 | 193 | 5 | C0010606 | |
| Disease | breast cancer (implicated_via_orthology) | 5.70e-04 | 25 | 193 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 6.27e-04 | 6 | 193 | 2 | EFO_0021231 | |
| Disease | body mass index, vital capacity | 6.27e-04 | 6 | 193 | 2 | EFO_0004312, EFO_0004340 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 6.27e-04 | 6 | 193 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Adult only | 6.27e-04 | 6 | 193 | 2 | C3842001 | |
| Disease | body weight | DPY19L3 NEXMIF PARK7 ADGRV1 ANLN BTN1A1 PCDH15 KAZN KIT PLXNA1 NID2 CHD8 PCDHA1 CEP192 NBAS HHIP DGKK TSPAN8 CNTNAP4 | 6.50e-04 | 1261 | 193 | 19 | EFO_0004338 |
| Disease | colorectal cancer | ABCC4 BTBD9 KAZN LILRB4 DOCK3 NID2 LIMA1 SH2B3 ZAP70 HHIP TSPAN8 SKOR1 | 6.68e-04 | 604 | 193 | 12 | MONDO_0005575 |
| Disease | cutaneous melanoma, hair color | 7.36e-04 | 62 | 193 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | Schizophrenia | ABCA1 PSD PDZK1 BTBD9 ARHGEF11 ALS2CL ITIH3 SETDB1 BRCA1 PIK3CA TAP1 PLXNA2 TSPAN8 DAAM2 PIP4K2C | 7.44e-04 | 883 | 193 | 15 | C0036341 |
| Disease | Prostatic Neoplasms | SERPINA3 ABCC4 IL16 PDZK1 TBC1D2 SETDB1 BRCA1 PIK3CA TAP1 ANXA4 PRKDC DNAJC3 | 7.92e-04 | 616 | 193 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | SERPINA3 ABCC4 IL16 PDZK1 TBC1D2 SETDB1 BRCA1 PIK3CA TAP1 ANXA4 PRKDC DNAJC3 | 7.92e-04 | 616 | 193 | 12 | C0376358 |
| Disease | Usher syndrome | 8.75e-04 | 7 | 193 | 2 | cv:C0271097 | |
| Disease | Usher Syndrome, Type III | 8.75e-04 | 7 | 193 | 2 | C1568248 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 8.88e-04 | 29 | 193 | 3 | C0496920 | |
| Disease | conotruncal heart malformations | 9.38e-04 | 114 | 193 | 5 | MONDO_0016581 | |
| Disease | Ovarian Carcinoma | 9.82e-04 | 30 | 193 | 3 | C0029925 | |
| Disease | Breast Cancer, Familial | 9.82e-04 | 30 | 193 | 3 | C0346153 | |
| Disease | hair color | 1.07e-03 | 311 | 193 | 8 | EFO_0003924 | |
| Disease | pantothenate measurement | 1.16e-03 | 8 | 193 | 2 | EFO_0021034 | |
| Disease | microcephaly (is_implicated_in) | 1.16e-03 | 8 | 193 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | progeria (implicated_via_orthology) | 1.16e-03 | 8 | 193 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | Distal arthrogryposis | 1.49e-03 | 9 | 193 | 2 | cv:C0265213 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.49e-03 | 9 | 193 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | diet measurement | KDM3B BCAT1 TENM2 DHH SLC35D3 BTN1A1 DESI1 SEMA4D SH2B3 ZKSCAN2 APOB NBAS MSH6 PTCD1 PRKDC ZNF287 | 1.54e-03 | 1049 | 193 | 16 | EFO_0008111 |
| Disease | bipolar disorder | DPY19L3 MAP2 KDM3B TUBGCP5 ITIH3 DHH PIM1 KIT ATP6V1H PLXNA4 TNKS | 1.54e-03 | 577 | 193 | 11 | MONDO_0004985 |
| Disease | Primary ciliary dyskinesia | 1.68e-03 | 36 | 193 | 3 | cv:C0008780 | |
| Disease | Lung diseases | 1.74e-03 | 78 | 193 | 4 | C0024115 | |
| Disease | Short Stature, CTCAE | 1.85e-03 | 10 | 193 | 2 | C2919142 | |
| Disease | Short stature | 1.85e-03 | 10 | 193 | 2 | C0349588 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.85e-03 | 10 | 193 | 2 | cv:C5675009 | |
| Disease | Global developmental delay | 1.86e-03 | 133 | 193 | 5 | C0557874 | |
| Disease | forced expiratory volume, body mass index | 2.25e-03 | 11 | 193 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | prostate carcinoma | TBC1D9 CEP350 ANLN PIM1 PCDH15 MLPH RAD51B TPCN2 NSD1 ZFAND4 LMNA LMO7 SOWAHB DNAH11 | 2.29e-03 | 891 | 193 | 14 | EFO_0001663 |
| Disease | fatty acid measurement | 2.41e-03 | 436 | 193 | 9 | EFO_0005110 | |
| Disease | sexual dimorphism measurement | BRPF3 ABCA1 EPPK1 SETDB1 BTN1A1 RAD51B DOCK3 LIMA1 CDC42BPA TRA2B INPP5E NSD1 APOB HHIP TNKS ATP6V0A2 | 2.60e-03 | 1106 | 193 | 16 | EFO_0021796 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.69e-03 | 12 | 193 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.85e-03 | 447 | 193 | 9 | C3714756 | |
| Disease | biliary liver cirrhosis | 3.00e-03 | 44 | 193 | 3 | EFO_0004267 | |
| Disease | fibromuscular dysplasia | 3.00e-03 | 44 | 193 | 3 | EFO_1000938 | |
| Disease | Breast Carcinoma | PDZK1 BRCA1 PIK3CA PIM1 BTK SLC39A6 KIT RAD51B SERPINB2 SMARCD1 | 3.00e-03 | 538 | 193 | 10 | C0678222 |
| Disease | Hyperlipoproteinemia Type IIb | 3.17e-03 | 13 | 193 | 2 | C1704417 | |
| Disease | Gastrointestinal Stromal Sarcoma | 3.62e-03 | 47 | 193 | 3 | C3179349 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.68e-03 | 14 | 193 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | obsolete_interleukin-12 subunit B measurement | 3.68e-03 | 14 | 193 | 2 | EFO_0010787 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 4.12e-03 | 99 | 193 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein triglyceride measurement | 4.23e-03 | 15 | 193 | 2 | EFO_0009946 | |
| Disease | Gastrointestinal Stromal Tumors | 4.31e-03 | 50 | 193 | 3 | C0238198 | |
| Disease | mammographic density measurement | 4.31e-03 | 50 | 193 | 3 | EFO_0005941 | |
| Disease | gastroesophageal reflux disease | 4.42e-03 | 101 | 193 | 4 | EFO_0003948 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 4.58e-03 | 102 | 193 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | ceramide measurement | 4.63e-03 | 235 | 193 | 6 | EFO_0010222 | |
| Disease | Hyperlipoproteinemia Type IIa | 4.81e-03 | 16 | 193 | 2 | C0745103 | |
| Disease | Abnormal behavior | 4.81e-03 | 16 | 193 | 2 | C0233514 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 5.43e-03 | 17 | 193 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 5.72e-03 | 173 | 193 | 5 | C0023467 | |
| Disease | ovarian cancer (is_implicated_in) | 5.92e-03 | 56 | 193 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Hypercholesterolemia, Familial | 6.08e-03 | 18 | 193 | 2 | C0020445 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALTGIESADKLLYTD | 556 | Q15361 | |
| LLSEDDSLYEGTFTR | 521 | Q60I27 | |
| ARLESDYTSFLEAKI | 376 | Q17RC7 | |
| EIFLKTDLDLDGYVS | 281 | Q9UBC2 | |
| DLRESSAKLYRDSSV | 2886 | Q96N23 | |
| LTDQSRSKLYDEESL | 2106 | Q9HCK8 | |
| LSKLTDIQYGREESD | 366 | P54687 | |
| RSTIKLEYEGTLFTE | 36 | Q5SY80 | |
| LFLYEDSKSVRLEDS | 316 | Q13410 | |
| KVSDFGLSRYVLDDE | 536 | Q06187 | |
| DRFTEDAKRLYGSEA | 151 | P01011 | |
| DKTLQDLVYDLSTSG | 176 | P36896 | |
| SYGISETTLEEIFLK | 1236 | O95477 | |
| KSGYTSRDLIILEND | 756 | Q8WXG9 | |
| ALGDILSKYEEDRSA | 456 | O15085 | |
| EKVFSYLSTISLEEG | 176 | Q5T7R7 | |
| SEVVDLDGKSSLLYR | 181 | Q9C0A0 | |
| IAFSRLEEGYETALK | 1756 | Q96DT5 | |
| LEKESYLESRSSGAQ | 191 | Q9ULD4 | |
| LEENKIYERSRSSDG | 251 | P20930 | |
| LLRSFGTDYVILEDS | 626 | Q6ZPD9 | |
| YKSTIGRDLIDDLKS | 56 | P09525 | |
| ALYTLSGETEELSRL | 1171 | Q9P1Y5 | |
| TLSDANRRKEYDTLG | 76 | Q9UBS3 | |
| EELIRDGRYTDATSK | 276 | Q13217 | |
| AEDRGDKFVLRSAYS | 396 | P17813 | |
| RSTDALRKIQESYGD | 41 | P20020 | |
| IRSRAEGYEKTDDVS | 11 | Q9Y2Q0 | |
| SEDYETALSGKEALS | 366 | Q96SN8 | |
| LEQDSSLKSYLSGEE | 286 | Q8N0V3 | |
| SLKSYLSGEEVEDDL | 291 | Q8N0V3 | |
| AREASSLKYLAEEFS | 236 | O15315 | |
| LSELKELSYRSLGED | 861 | Q96L73 | |
| STSGELTIIKDLDYE | 296 | Q9Y5H1 | |
| SVTLLVLDGDSYEKA | 81 | Q5T2W1 | |
| EDYIKSLSDSFRVGD | 71 | Q8N635 | |
| QKELGSTEDIYLASR | 651 | Q86T65 | |
| SLKGLYDDTTAFLDE | 1151 | Q5KSL6 | |
| YDDTTAFLDEKLLRS | 1156 | Q5KSL6 | |
| KQSLEASLAETEGRY | 386 | P13645 | |
| EESKILITDFGLAYS | 196 | Q96QS6 | |
| YEAELGDARKTLDSV | 81 | P02545 | |
| SAISELLERLKSYGE | 4576 | Q9NU22 | |
| EDYRDAEAGRSLSKA | 506 | Q674X7 | |
| TLDSGKTLAEISDRY | 136 | Q8WWB3 | |
| EKLTETARELGYSLE | 191 | A8MVJ9 | |
| GRKISENSYSLDDLE | 221 | Q9UHB6 | |
| KDVRSRSYLEGSLLA | 266 | Q9NRR6 | |
| VSKASYLLREGEEFT | 216 | P10721 | |
| LTADDLRAKYEAEVS | 176 | Q6A163 | |
| GTLEAREYRLDKEES | 51 | Q8NHJ6 | |
| KLEDSFEALSLYLGE | 596 | P53671 | |
| YSDDSRALDKLIDGT | 1261 | O60303 | |
| SLGSEDRDLLYSIDA | 661 | Q9NQW6 | |
| EEEAIKRSRSLSESY | 96 | Q6DN90 | |
| SIYKLTDFGAARELD | 151 | Q14164 | |
| TGLKALYETELADAR | 76 | P20700 | |
| LASADIETYLLEKSR | 261 | P13535 | |
| SLSVDEDYDLRLSGL | 1531 | Q9H6A9 | |
| TGEARYSLSEDKLIR | 1481 | Q9UIW2 | |
| AITGEARYSLSEDKL | 1476 | O75051 | |
| TGEARYSLSEDKLIR | 1456 | P51805 | |
| AITGEARYSLSEDKL | 1476 | Q9HCM2 | |
| EETAKLAVGRLSEYS | 201 | O43157 | |
| YSENRVEKDGLILTS | 141 | Q99497 | |
| LETSSLLDYEGTKEF | 421 | Q9HC56 | |
| LASADIETYLLEKSR | 261 | Q9UKX2 | |
| SYEGSDLAAREKVVL | 151 | Q5XG92 | |
| LSELREYTEGLTEAK | 1051 | Q14005 | |
| RKESLSDSRDLDGSY | 6 | Q9NS61 | |
| SSLAEGIDLETSKYI | 976 | Q7LBC6 | |
| LASDDFRTKYETELS | 136 | O76009 | |
| EEFKAGSRVLESIYS | 376 | Q6ZV70 | |
| GDRNKSRSTTELDDY | 1416 | Q8WWI1 | |
| DAERKSLYTLFLESV | 586 | Q96RT8 | |
| LASADIETYLLEKSR | 261 | P12882 | |
| YFTLKTSADLDRETV | 406 | Q9UN70 | |
| TLLEEEYFREKLSDG | 636 | P52701 | |
| SYEKSIDLVLAASRE | 1166 | A2RRP1 | |
| YFGELLADLSRKNTD | 256 | Q8WVV4 | |
| IFSALGIESEDDLYK | 531 | Q96MC2 | |
| KGEIYDAAIDLFTRS | 886 | P42336 | |
| DSSSGEIRLIDKLDY | 296 | Q9Y5I3 | |
| VFSYTADKEIRTDDL | 466 | Q8IUC8 | |
| RLTISALEKADSDTY | 2971 | Q5VST9 | |
| KAELRVDLTSTDYDT | 5211 | Q5VST9 | |
| YFLETSRDVKRLEST | 881 | O15439 | |
| ESALLDGSERKVLFY | 1211 | Q14112 | |
| LIRAIDSSNLKDDYS | 191 | Q5JVF3 | |
| TLGKALDRESTDRYI | 671 | Q96QU1 | |
| EYSGSSEKIDLLASD | 421 | P38398 | |
| SDTADFRDLYTKVLE | 501 | P81408 | |
| SGFLDLKEVDELLYT | 886 | A4FU69 | |
| DESTEGKTSYRLTLD | 1081 | P04114 | |
| TGEVKLASALDYETL | 76 | Q9BYE9 | |
| YKDDRLLSSGTAEGL | 251 | A6NGN9 | |
| DLSGSESLEFLKVDY | 61 | Q8NFQ6 | |
| EDTESGKTLLLDAYR | 1851 | Q9Y6J0 | |
| KGDESYRELFSLLTQ | 1151 | Q8IZD9 | |
| ALDITTSDRDRNKYG | 146 | O43323 | |
| LSDGLSEEDFSIYSR | 806 | Q92562 | |
| SIDTVRYGKESDLGD | 736 | Q8IW35 | |
| GSSSSLALEDYVEKE | 856 | Q8ND61 | |
| RRDVDLDLSDKDYSS | 751 | Q9HC77 | |
| EEIFLEYLSSLGESL | 81 | Q6ICB0 | |
| DRFEGISEAASKEYS | 886 | Q8WXX0 | |
| KRYEVGLEKLDSASS | 2586 | Q8WXX0 | |
| ELYKDDFEVSSLLSL | 2391 | Q5VT06 | |
| LVEEYEGTSALKELS | 101 | Q9P203 | |
| KEKTEDRYSLGSSLD | 141 | Q9P2E8 | |
| YLLLGRKSSELDASD | 361 | P27448 | |
| TSDLDKDDASYLRLS | 566 | Q8TEP8 | |
| GKFRSLLFTSEDDER | 226 | P43166 | |
| RKYESDEDSLGSSGR | 466 | O00418 | |
| LRTYATIDKTRDAEA | 231 | Q14746 | |
| GLTSDERKLLEEAYS | 646 | Q8TDG4 | |
| SISSFSYREILREKE | 666 | Q4V328 | |
| YTGRATLTDEKEEVL | 96 | Q96Q07 | |
| DKISFDLSLARGLDY | 316 | P12081 | |
| YAAEDKTSVDDRLSI | 161 | Q8NE79 | |
| LYLEDLDLSSSESGT | 736 | Q6P995 | |
| ASSDSRGYDLQKEVL | 566 | B7ZC32 | |
| DLSSLEEYLASLGRK | 81 | Q9NPG2 | |
| DYLKGFLEESVSALD | 246 | A6NMZ7 | |
| VDITTSDRDRNKYGL | 151 | Q14623 | |
| DDDSFDRKSVYRGSL | 561 | Q9BV36 | |
| AGSESRRYSVAEEKE | 26 | Q9Y5E6 | |
| KYDLKGSLVSREASD | 216 | Q8TBX8 | |
| STGLELLESEITYDK | 276 | P05120 | |
| DYSDTVKDLVSRFLV | 256 | Q16816 | |
| ALLKDTVYTDFDGTR | 191 | P11309 | |
| KLLEEEATTYTFSRA | 206 | P59025 | |
| DTESIAKLYGSAREA | 601 | P84550 | |
| TLSDFESGLKYITDV | 1416 | O75691 | |
| SSEEGSRRSLKDAYL | 376 | Q5M8T2 | |
| EEYKRLSEALAEDGS | 131 | Q12872 | |
| SFDEYSSELKSGRLE | 351 | Q9UI12 | |
| SADSVYTKVRLLEGE | 21 | Q5T2D2 | |
| AVGRAAKYSETDLDT | 276 | A5PKW4 | |
| VEGRLLEDSALSKYD | 211 | Q96GM5 | |
| AGSKVTFELTYEELL | 146 | Q06033 | |
| ESGTASFEKLRDSDY | 1476 | Q5QGS0 | |
| KSEGEASLYEDRIIT | 506 | Q96NG3 | |
| SERDLASSTKGLEYA | 1221 | Q8NFP9 | |
| IVLRDLEFSDTGKYT | 116 | Q8IWT1 | |
| EKLLSAERAVTGYTD | 4966 | P58107 | |
| AVGSSEKIFEYLDRT | 471 | Q03518 | |
| VIFDYSDDGRILKTS | 1996 | Q9NT68 | |
| LASADIETYLLEKSR | 261 | Q9Y623 | |
| TGKLASADIETYLLE | 256 | P11055 | |
| SALLLSEDKDTLYIG | 51 | Q92854 | |
| TGKLASADIETYLLE | 256 | P13533 | |
| SALDGRETDFYKLSE | 1296 | Q5VT25 | |
| LAGRAKLSSSDEEYL | 501 | A6NEL2 | |
| KLSSSDEEYLDEGLL | 506 | A6NEL2 | |
| EDELGEVYILSSSKS | 556 | Q96QV1 | |
| LEYSRGLEKLAERFS | 61 | P98171 | |
| SKLGLQYRDSSSEDE | 101 | Q15047 | |
| RYSREELKDAGVATL | 581 | Q13433 | |
| RLEETARALYSLGSK | 336 | P54922 | |
| ARALYSLGSKEDTVI | 341 | P54922 | |
| SEKAFGVLSETLYEL | 126 | Q9UNS1 | |
| SGKSDELIRYQEELS | 271 | O60296 | |
| YIETALDGRKESEAL | 96 | Q6NUS8 | |
| SSLTREEAERKLYSG | 166 | P43403 | |
| SGYELSEAKAILTEL | 211 | Q6AWC2 | |
| ERGFSLKSVLSQEYD | 291 | Q9HBT7 | |
| VSAYVDTTADLDRKL | 91 | Q496A3 | |
| ASEFLDEALLTYRGK | 206 | Q5VZP5 | |
| ENSLKTDDYGRDLSS | 1996 | Q13813 | |
| RTSDVDYRLLEASKA | 646 | O95271 | |
| DYRLLEASKAGDLET | 651 | O95271 | |
| YETTGLSEAREKAVL | 266 | Q15833 | |
| TSYEKFGTIRADLIE | 776 | Q6ZT07 | |
| SGLSLEEYKLILSTD | 81 | Q9BRT2 | |
| LKEAVLRYSLADEAS | 196 | Q9UQQ2 | |
| GLDSTSVFEDLKKYL | 711 | Q4J6C6 | |
| LSVRLEFDYSEDKSS | 2261 | O95359 | |
| EKYILRGDETFAVLS | 241 | Q9H857 | |
| DALDSSSILYARKDS | 56 | Q8TC07 | |
| AKGDRTSDLISLYEE | 246 | Q6PF05 | |
| SYLESKGLLATASED | 216 | Q9NNW5 | |
| DLSSQFYLREEDIGK | 111 | P22314 | |
| FYEGTDDKVRRDLAT | 896 | P11137 | |
| AQGEYDKLLFRSDTL | 1241 | P11137 | |
| LDGYLKTSALSDETK | 796 | P78527 | |
| ALLAEARSDYSEAAK | 2956 | P78527 | |
| TSIKRYDGDITDLGL | 831 | Q7Z3V4 | |
| GSDLSAEDRELLKAY | 581 | Q9H6S0 | |
| ASTYLARLGLSESDE | 156 | Q9UPU5 | |
| GYEETKTFLDILRET | 501 | Q63HK3 | |
| AALEYVEISKGETSR | 211 | Q5W5X9 | |
| IKLSDYDSSEEAIRT | 361 | Q6PGP7 | |
| DDLTRKFTYLGSQDR | 291 | Q7Z2W4 | |
| ERYISSITGEFLKED | 306 | Q86XD8 | |
| KRDLEPSDATYTALF | 201 | O75127 | |
| DSDFILTEGDLTLTY | 651 | Q96T83 | |
| RSLAEEYGLDTINKD | 396 | Q13564 | |
| RLSSTDDGYIDLQFK | 21 | Q96A57 | |
| SLYTTERDLREVFSK | 126 | P62995 | |
| ILSFTYTGDRSKDEE | 311 | O95125 | |
| EVDSLLSRYAEKALD | 1716 | Q68DK2 | |
| DKYVDSFGRTLEDLT | 311 | O95932 | |
| EKVRSYGSVLLSAEE | 381 | Q8NHX9 | |
| LYENTKLLSATGESE | 121 | P19075 | |
| SSAYLAAAEDKDRLE | 346 | Q9BYX2 | |
| SVYKLTDFGAARELE | 151 | Q9UHD2 | |
| SLYSGKDSDSVKLLE | 76 | Q9H0D2 | |
| SGYTLIRKDSEEEVS | 686 | Q9Y487 | |
| KRDTDITSESDYGNR | 326 | Q9C099 | |
| SEYAISEKSERSLAL | 2386 | B2RTY4 | |
| DGVELTREDSFKARY | 381 | Q14324 |